Search

everythinglearnresearchcommunity

for

Search:↓

Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.

Uncombable hair syndrome causes frizzy hair and can affect the nervous system, eyes, and ears, often co-occurring with other hair, skin, nail, and teeth conditions, and is linked to three specific gene mutations.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Two nutritional supplements improved hair growth and reduced hair loss in women with hair loss conditions.

The document explains various skin conditions and their treatments.

The document concludes that non-scarring alopecias can be reversed, but scarring alopecias cause permanent hair loss.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

Using your own platelet-rich plasma (PRP) can effectively treat hair loss, increasing hair density and width with no side effects.

Computer-aided imaging system accurately measures baldness in Chinese women with hair loss.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

Scalp cooling can help prevent hair loss from chemotherapy, but treatment should be tailored to the individual and more research is needed.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Skin color may change how alopecia areata looks under a dermoscope.

Yellow dots are common in severe alopecia areata.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Women of child-bearing age with androgenic alopecia lose hair density, especially in certain areas, and their hair becomes thinner. They also lose more than twice as much hair as healthy women.

Mutations in three genes cause Uncombable Hair Syndrome, leading to frizzy hair that can't be combed flat.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Machine learning can accurately identify Alopecia Areata, aiding in early detection and treatment of this hair loss condition.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

COVID-19 can cause hair loss starting as early as 18 days after infection.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

Using both minoxidil and platelet-rich plasma therapy together is more effective for hair growth in women than using minoxidil alone.

Hospital staff have a higher rate of hair loss than the general population.